VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SCL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SCLStepan Company
$54.65$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSCLCash Flow

Stepan Company (SCL) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash flow generation is highly erratic, demonstrated by a 2026Q1 net loss of $41.4 million occurring alongside $16.9 million in operating cash flow, further strained by capital expenditures that reached 16.4% of revenue in 2025Q4.

SCL Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations157.87M147.88M162.05M174.88M160.76M72.14M235.22M218.43M171.13M198.86M212.16M183.27M81.95M150.31M108.97M77.38M66.13M166.44M29.13M47.08M38.83M42.09M43.86M45.57M46.07M53.43M53.53M50.6M58.8M62.9M65.8M
Operating CF Margin %-6.34%7.43%7.52%5.8%3.07%12.58%11.75%8.58%10.33%12.01%10.32%4.25%7.99%6.04%4.2%4.62%13.04%1.82%3.54%3.31%3.9%4.69%5.81%6.15%7.51%7.66%7.59%9.63%10.81%12.26%
Operating CF Growth %276.87%-8.74%-7.33%8.78%122.86%-69.33%7.69%27.64%-13.95%-6.27%15.76%123.63%-45.48%37.94%40.83%17.01%-60.27%471.37%-38.12%21.24%-7.75%-4.04%-3.74%-1.08%-13.77%-0.2%5.79%-13.95%-6.52%-4.41%88%
Net Income-14.22M46.9M50.37M40.2M147.15M137.9M127.66M103.1M112.75M91.55M86.2M76.04M57.08M72.34M79.69M72.6M65.59M63.1M37.17M15.12M6.67M13.16M10.32M4.91M20.13M16.07M15.01M22.1M23.5M20.4M19.1M
Depreciation & Amortization129.72M126.04M112.2M105.34M94.65M90.88M81.86M78.7M81.11M79.02M74.97M66.98M63.8M56.4M51.29M47.1M40.35M37.17M36.93M37.18M38.38M38.77M39.17M41.43M40.12M39.97M39.28M39.5M37.3M35.3M32.1M
Stock-Based Compensation8.31M2.15M5.35M5.74M13.85M11.72M10.08M8.87M6.84M7.15M12.62M4.37M-68K2.78M3.12M3.68M3.79M4.75M3.7M000000000000
Deferred Taxes-14.72M-1.4M-10.29M18.3M-27.45M-33.6M-4.51M-5.02M10.86M550K-8.43M3M5.31M259K134K5.06M5.37M8.19M1.28M4.7M-10.14M-5.41M-4.31M-5.77M-466K-2.43M-3.9M3.7M4.2M1.1M-1.7M
Other Non-Cash Items56.24M-3.78M1.64M7.22M1.52M6.76M9.91M13.43M5.26M5.54M23.99M9.87M-4.52M10.7M4.31M3.7M1.76M7.87M-13.44M3.46M4.47M2.42M-1.14M1.47M-1.46M526K1.74M-10.2M-7.6M1.9M18.5M
Working Capital Changes-7.46M-22.04M2.79M-1.93M-68.96M-141.51M10.21M19.34M-45.69M15.06M22.82M23.01M-39.64M7.83M-29.58M-54.76M-50.73M45.35M-36.51M-13.38M-557K-6.85M-182K5.09M-12.11M-574K1.41M-4.5M1.4M4.9M-2.2M
Change in Receivables17.88M23.72M9.04M32.01M-54.17M-104.23M-23.42M4.89M5.2M-16.36M-17.18M4.16M-21.23M-12.75M3.91M0000000000000000
Change in Inventory28M500K-37.18M144.85M-99.39M-79.26M-15.36M28.46M-26.83M5.66M-3.77M2.85M-18.52M-3.79M-50.26M-12.85M-16.98M31.82M-24.04M-710K-4.61M-1.52M-4.01M-2.56M-8.65M-167K-8.28M600K-2.8M1.2M4.1M
Change in Payables-49.88M-32.71M33.97M-158.92M54.17M44.41M38.79M-13.24M-18.19M28.84M44.29M16.41M3.55M19.95M21.78M0000000000000000
Cash from Investing-85.55M-89.05M-116.94M-258.67M-308.09M-376.83M-139.03M-112.67M-107.81M-82.68M-130.52M-125.97M-109.22M-167.56M-87.45M-101.39M-97.25M-34.74M-43.05M-35.32M-48.49M-41.56M-28.09M-34.19M-35.49M-56.76M-29.56M-33.7M-63.7M-40.2M-48.5M
Capital Expenditures-177.13M-122.51M-122.78M-260.33M-301.55M-194.48M-125.79M-105.57M-86.65M-78.61M-103.08M-119.35M-101.82M-92.86M-83.16M-83.17M-73.75M-42.63M-49.78M-39.81M-45.97M-41.52M-33.77M-32.87M-36.13M-34.01M-28.44M-33.2M-44.1M-35.6M-44.9M
CapEx % of Revenue7.56%5.25%5.63%11.19%10.87%8.29%6.73%5.68%4.35%4.08%5.84%6.72%5.28%4.94%4.61%4.51%5.15%3.34%3.11%2.99%3.92%3.85%3.61%4.19%4.83%4.78%4.07%4.98%7.22%6.12%8.37%
Acquisitions26.59M26.59M00-9.69M-184.47M-13.52M-9M-22.85M-4.34M-23.51M-1.87M0-68.21M0-13.56M-20.23M08.91M5.85M0000-2.19M-24.64M00000
Investments-------------------------------
Other Investing65M6.88M5.83M1.67M3.16M2.13M277K1.91M1.68M269K-3.94M-5.65M-8.31M-7.18M-4.83M-6.27M-4.05M4.29M-2.33M-1.35M-2.52M-37K5.68M-1.32M2.83M1.89M-1.12M-500K-19.6M400K-3.6M
Cash from Financing-44.6M-35.44M-64.52M33.28M166.21M117.33M-64.93M-90.49M-51.65M-50.5M-29.77M42.93M-15.49M76.25M-29.48M-2.1M42.37M-41.96M17.11M-11.85M-1.75M9.78M-14.09M-10.07M-9.86M4.21M-24.4M-13.9M300K-21.9M-15.6M
Debt Issued (Net)-7.57M1.24M-28.68M66.86M223.69M165M-23.57M-53.92M-14.67M-26.72M-13.78M60.69M6.49M87.2M-17.69M19.34M52.87M-38.99M17.4M-5.5M2.73M17.52M-6.71M-2.02M-2.64M14.28M-9.03M600K13.5M-8.5M-6.3M
Equity Issued (Net)316K104K1.11M2.79M-24.95M-16.97M-15.25M-13.18M-15.5M-6M-2.41M-2M-7.92M-2.27M2.38M1.72M-4.91M-1.93M01.82M3.3M506K655K-450K576K-1.44M-7.33M-7.2M-5.9M-6.6M-3.5M
Dividends Paid-35.31M-35.03M-33.95M-32.87M-30.57M-28.08M-25.41M-23.1M-20.86M-18.91M-17.33M-16.3M-15.39M-14.47M-12.76M-11.51M-10.57M-9.56M-8.86M-8.43M-8.15M-7.87M-7.73M-7.58M-7.34M-7.35M-7M-6.7M-6.4M-6.1M-5.8M
Share Repurchases0000-24.95M-16.97M-15.25M-13.18M-15.5M-6M-2.41M-2M-7.92M-2.27M-2.1M-1.51M-4.91M-1.93M0000-30K-2.71M-2.02M-4.59M-8.73M-8.3M-8.4M-8.9M-3.5M
Other Financing-2.04M-1.76M-3M-3.5M-1.96M-2.62M-705K-289K-622K1.13M3.74M104K1.33M5.8M-1.4M-11.65M4.98M8.52M8.57M257K370K-380K-302K-26K-452K-1.29M-1.03M-600K-900K-700K0
Net Change in Cash33.28M33.02M-30.16M-43.93M14.56M-190.75M34.55M15.19M1.3M73.15M49.6M90.93M-48.13M56.47M-7.22M-27.1M12.68M90.26M2.52M370K-11.27M10.38M2.03M1.05M-1.04M688K-433K3M300K-21.9M-15.6M
Free Cash Flow-19.26M25.37M39.28M-85.46M-140.79M-122.35M109.42M112.86M84.48M120.25M109.09M63.92M-19.86M57.45M25.81M-5.79M-7.62M123.81M-20.65M7.26M-7.14M573K10.1M12.7M9.93M19.41M25.09M17.4M14.7M27.3M20.9M
FCF Margin %-0.82%1.09%1.8%-3.67%-5.08%-5.22%5.85%6.07%4.24%6.25%6.18%3.6%-1.03%3.05%1.43%-0.31%-0.53%9.7%-1.29%0.55%-0.61%0.05%1.08%1.62%1.33%2.73%3.59%2.61%2.41%4.69%3.89%
FCF Growth %-121.72%-35.41%145.96%39.3%-15.07%-211.81%-3.04%33.58%-29.74%10.23%70.65%421.81%-134.58%122.58%545.85%24.05%-106.16%699.62%-384.41%201.65%-1346.42%-94.33%-20.47%27.83%-48.84%-22.63%44.2%18.37%-46.15%30.62%597.62%
FCF per Share-0.841.111.71-3.72-6.10-5.254.714.843.625.144.722.80-0.872.511.14-0.26-0.345.73-0.980.36-0.380.030.560.700.511.001.280.890.691.240.94
FCF Conversion (FCF/Net Income)1.35x3.15x3.22x4.35x1.09x0.52x1.86x2.12x1.52x2.17x2.46x2.41x1.44x2.06x1.37x1.08x1.01x2.64x0.78x3.11x5.82x3.20x4.25x9.28x2.29x3.32x3.57x2.29x2.50x3.08x3.45x
Interest Paid6.7M0027.95M16.53M9.54M9.33M12.25M12.83M13.89M14.73M11.94M12.45M11.28M10.49M8.65M6.63M6.89M9.62M000000000000
Taxes Paid-525K0029.56M41.62M92.87M39.02M29.33M32.97M25.66M30.58M21.78M23.14M22.69M29.7M24.33M25.09M28.81M7.63M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Feedstock cost volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Lacks Cash Support

As reported in recent financial statements, the relationship between net income and operating cash flow is highly erratic, evidenced by a 2026Q1 net loss of $41.4 million alongside positive operating cash flow of $16.9 million, suggesting significant non-cash adjustments and accrual-based distortions in reported earnings.

The wide divergence between net income and operating cash flow indicates that reported profitability is frequently decoupled from actual cash generation. Investors should monitor this disconnect, as it suggests that accounting earnings may not be a reliable proxy for the company's underlying ability to fund operations through internal cash flows.

Free Cash Flow Remains Volatile

Based on quarterly data, Stepan's free cash flow trajectory is inconsistent, with negative FCF margins reaching -5.6% in 2025Q4, which highlights the company's struggle to maintain positive cash generation after accounting for necessary capital expenditures in a cyclical and capital-intensive chemical manufacturing environment.

The inability to consistently generate positive free cash flow suggests that the company's capital requirements often outpace its operational cash generation. This trend warrants further investigation into whether current capital spending is truly growth-oriented or merely required to maintain existing, low-margin production capacity.

Working Capital Swings Impair Liquidity

According to recent SEC filings, working capital changes have been a major source of cash flow volatility, with a $44.0 million outflow in 2025Q1 followed by a $32.3 million inflow in 2025Q4, indicating that inventory and receivables management remains highly sensitive to fluctuating feedstock and demand cycles.

These sharp swings in working capital suggest that the company's cash position is heavily influenced by the timing of raw material purchases and customer payments. Such volatility complicates cash flow forecasting and may indicate that the company lacks the leverage to optimize its cash conversion cycle effectively.

Capital Intensity Pressures Cash Reserves

As reported in financial statements, capital expenditures have remained elevated, peaking at 16.4% of revenue in 2025Q4, which suggests that the company is forced to commit significant capital to maintain its infrastructure despite the thin operating margins currently characterizing its core surfactant and polymer business segments.

The high capital intensity relative to revenue appears to be a structural burden that limits the company's financial flexibility. If these expenditures do not lead to a meaningful improvement in operating margins, the company may face continued pressure on its ability to sustain dividends and internal investment.

SCL — Frequently Asked Questions

Quick answers to the most common questions about buying SCL stock.

How much cash does Stepan Company (SCL) generate from operations?

Stepan Company (SCL) generated $147.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Stepan Company's free cash flow?

Stepan Company (SCL) generated $25.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Stepan Company's capital expenditure (CapEx)?

Stepan Company (SCL) spent $122.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Stepan Company distribute cash to shareholders?

In 2025, Stepan Company (SCL) returned $35.0M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.